Skip to content

Immunoclin Corp: 10-Q filed 2013-10-21

What Immunoclin Corp reported in its quarterly report filed 2013-10-21 (fiscal Q2 2013): 12 published measures, 37 facts as tagged in accession 0001517126-13-000303.

This filing

Form
10-Q (quarterly report)
Filed
2013-10-21
Fiscal period
fiscal Q2 2013
Accession
0001517126-13-000303 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Immunoclin Corp filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2013-08-31608,396USD
At 2013-02-2833USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2013-08-3183,489USD
At 2013-02-2865,798USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2013-08-31524,907USD
At 2013-02-28-65,765USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2013-06-01 to 2013-08-31-65,936USD92
2013-03-01 to 2013-08-31-110,835USD184
2011-02-08 to 2013-08-31-201,870USD936
2012-06-01 to 2012-08-3127,221USD92
2012-03-01 to 2012-08-3110,957USD184

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2011-02-08 to 2013-08-31-38,105USD936
2012-03-01 to 2012-08-31-7,547USD184

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2013-03-01 to 2013-08-31-33USD184
2011-02-08 to 2013-08-3138,105USD936
2012-03-01 to 2012-08-31-4,835USD184

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2013-06-01 to 2013-08-31-65,936USD92
2013-03-01 to 2013-08-31-110,835USD184
2011-02-08 to 2013-08-31-241,370USD936
2012-06-01 to 2012-08-31-12,279USD92
2012-03-01 to 2012-08-31-28,543USD184

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2013-06-01 to 2013-08-3165,936USD92
2013-03-01 to 2013-08-31110,835USD184
2011-02-08 to 2013-08-31241,370USD936
2012-06-01 to 2012-08-3112,279USD92
2012-03-01 to 2012-08-3128,543USD184

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2013-08-3110,361,015shares
At 2013-02-285,361,015shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2013-08-31716,416USD
At 2013-02-2819,909USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2013-06-01 to 2013-08-313,926USD92
2013-03-01 to 2013-08-314,219USD184
2011-02-08 to 2013-08-3113,313USD936
2012-06-01 to 2012-08-311,487USD92
2012-03-01 to 2012-08-311,959USD184

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2011-02-08 to 2013-08-3125,270USD936
2012-03-01 to 2012-08-3112,551USD184

Inspect the source

Entity
Immunoclin Corp / CIK 0001520047
Captured
SEC response SHA-256
cdfbf3ddd493bed046dd28be8c53e20201b60478d7022019645c6ed835ac7b05

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001520047.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))